Risk Factors and Incidence of Infection During Induction Chemotherapy for High Risk Neuroblastoma

被引：0
|
作者：
Whittle, Sarah [1 ]
Williamson, Kaitlin [1 ]
Russell, Heidi [1 ]
机构：
[1] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
850
引用
收藏
页码：S71 / S72
页数：2
相关论文
共 50 条
  • [31] Letter to the Editor: Reflections on "Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk Neuroblastoma"
    Wang, Haoru
    Chen, Xin
    He, Ling
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (13) : 8692 - 8693
  • [32] ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk Neuroblastoma
    Sara A. Mansfield
    M. Beth McCarville
    John T. Lucas
    Matthew J. Krasin
    Sara M. Federico
    Victor M. Santana
    Wayne L. Furman
    Andrew M. Davidoff
    Annals of Surgical Oncology, 2021, 28 : 708 - 709
  • [33] ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk Neuroblastoma
    Mansfield, Sara A.
    McCarville, M. Beth
    Lucas, John T., Jr.
    Krasin, Matthew J.
    Federico, Sara M.
    Santana, Victor M.
    Furman, Wayne L.
    Davidoff, Andrew M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 708 - 709
  • [34] Histological features of primary tumors after induction or high-dose chemotherapy in high-risk neuroblastoma
    Hishiki, Tomoro
    Horie, Hiroshi
    Higashimoto, Yasuyuki
    Yotsumoto, Katsumi
    Komatsu, Shugo
    Okimoto, Yuri
    Kakuda, Harumi
    Taneyama, Yuichi
    Saito, Takeshi
    Terui, Keita
    Mitsunaga, Tetsuya
    Nakata, Mitsuyuki
    Ochiai, Hidemasa
    Hino, Moeko
    Ando, Kumiko
    Yoshida, Hideo
    Iwai, Jun
    PEDIATRIC SURGERY INTERNATIONAL, 2014, 30 (09) : 919 - 926
  • [35] Disseminated Cunninghamella bertholletiae Infection During Induction Chemotherapy in a Girl with High-Risk Acute Lymphoblastic Leukemia
    Su, Yung-Yueh
    Chang, Tsung-Yen
    Wang, Chao-Jan
    Jaing, Tang-Her
    Hsueh, Chuen
    Chiu, Cheng-Hsun
    Huang, Yhu-Chering
    Chen, Shih-Hsiang
    PEDIATRICS AND NEONATOLOGY, 2016, 57 (06): : 531 - 534
  • [36] Incidence and Risk Factors for Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
    Versluis, Jurjen
    Flamand, Yael
    Haydu, Erika J.
    Vedula, Rahul S.
    Charles, Anne
    Copson, Kevin
    Wolach, Ofir
    Bendapudi, Pavan
    Belizaire, Roger
    Neuberg, Donna S.
    Luskin, Marlise R.
    Lindsley, R. Coleman
    BLOOD, 2020, 136
  • [37] I-131-mIBG therapy in high-risk neuroblastoma patients at end of induction chemotherapy
    Schmidt, M. C.
    Hero, B.
    Decarolis, B.
    Eggert, A.
    Berthold, F.
    Drzezga, A.
    Simon, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S772 - S772
  • [38] TUMOR HISTOLOGY FOLLOWING INDUCTION CHEMOTHERAPY AND/OR HIGH-DOSE CHEMOTHERAPY AND ITS IMPACT ON THE OUTCOME OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA
    Hishiki, T.
    Horie, H.
    Higashimoto, Y.
    Yotsumoto, K.
    Komatsu, S.
    Okimoto, Y.
    Kakuda, H.
    Taneyamai, Y.
    Yoshida, H.
    Iwai, J.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S331 - S331
  • [39] Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma
    Kushner, BH
    Kramer, K
    LaQuaglia, MP
    Modak, S
    Yataghene, K
    Cheung, NKV
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (24) : 4888 - 4892
  • [40] Factors Associated with Prolonged Hospital Stay during Induction Chemotherapy for High Risk Pediatric Acute Lymphoblastic Leukemia
    Warrick, Kasper
    Althouse, Sandra K.
    Rahrig, April
    Joy, Rupenthal
    Batra, Sandeep
    BLOOD, 2017, 130
12345